News
Revolut scraps US merger plans in favour of push for standalone licence
Stay informed with free updatesSimply sign up to the Fintech myFT Digest -- delivered directly to your inbox.Revolut has scrapped…
Editor's Top Picks
French supertax on wealthy raises only a quarter of planned revenue
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.A special…
Your one-stop resource for personal news and tips.
More form News
I’m Out! Quiet Quitting This Market
Co-Authored by Treading Softly I've never been one to really get caught up in the…
‘He is driven by demons’: biographer Walter Isaacson on Elon Musk
It is late morning on a Friday in Galatoire’s Restaurant on Bourbon Street, New Orleans…
Autolus: CAR-T Therapy Looks Promising (NASDAQ:AUTL)
Autolus (NASDAQ:AUTL) is a CAR-T therapy developer with in-house manufacturing, multiple collaborations and a lead…
European stocks gain as Chinese inflation data stokes optimism
Receive free Capital markets updatesWe’ll send you a myFT Daily Digest email rounding up the…
Pinnacle West Stock: Stellar Outperformance Amongst Utilities (NYSE:PNW)
Our last coverage of Pinnacle West (NYSE:PNW) we gave a neutral rating to the utility,…
China gives strong warning against bets on renminbi depreciation
Receive free Renminbi updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
John B. Sanfilippo & Son: Why Nut (NASDAQ:JBSS)
It was in early 2015 when I urged a cautious tone on shares of John…
Sunak’s foreign policy reset overshadowed by espionage
Receive free UK politics updatesWe’ll send you a myFT Daily Digest email rounding up the…
Should Retail Opportunity Investments, With Good ROIC, Be On Your Watchlist? (NASDAQ:ROIC)
Dear subscribers, Portfolios and assets on the West Coast have, in large part, been selling…
ECB grapples with knife-edge decision on interest rates
Receive free Eurozone interest rates updatesWe’ll send you a myFT Daily Digest email rounding up…
The AAT Caveat In Kamada’s Upbeat Quarter (NASDAQ:KMDA)
Introduction Kamada (NASDAQ:KMDA) is a biopharmaceutical firm, based in Israel, specializing in plasma-derived products for…
Finance hits back against US regulator’s rulemaking spree
Securities and Exchange Commission chair Gary Gensler’s ambitious regulatory agenda is igniting fierce opposition from…
Bridge Investment Group: Impressive AUM Growth Should Fuel Dividend Growth
Introduction The development of the share price for Bridge Investment Group Holdings Inc. (NYSE:BRDG) over…
Departing Alibaba chief Daniel Zhang steps down from cloud unit
Receive free Alibaba updatesWe’ll send you a myFT Daily Digest email rounding up the latest…
Burford Capital’s Valuation After The Bull Case Damages Win (NYSE:BUR)
This year was tumultuous for Burford (NYSE:BUR) in a positive sense, with: early inflection of…